ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 94 filers reported holding ANTARES PHARMA INC in Q3 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,820,000 | -81.6% | 3,983,440 | -74.2% | 0.20% | -80.8% |
| Q3 2015 | $26,267,000 | -31.3% | 15,451,124 | -16.0% | 1.02% | -20.3% |
| Q2 2015 | $38,251,000 | +16.9% | 18,389,789 | +52.3% | 1.27% | +20.2% |
| Q1 2015 | $32,732,000 | +57.2% | 12,078,318 | +49.0% | 1.06% | +41.7% |
| Q4 2014 | $20,828,000 | +45.5% | 8,104,318 | +3.6% | 0.75% | +43.3% |
| Q3 2014 | $14,317,000 | -44.2% | 7,823,618 | -18.5% | 0.52% | -49.4% |
| Q2 2014 | $25,642,000 | -22.8% | 9,603,703 | +1.2% | 1.03% | -24.0% |
| Q1 2014 | $33,210,000 | -26.8% | 9,488,461 | -6.4% | 1.36% | -42.3% |
| Q4 2013 | $45,341,000 | +29.1% | 10,141,174 | +17.2% | 2.35% | +43.8% |
| Q3 2013 | $35,132,000 | -10.2% | 8,653,119 | -7.9% | 1.63% | -11.3% |
| Q2 2013 | $39,104,000 | – | 9,400,000 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |